This content is machine translated Results of the FOREST HCM study Symptomatic obstructive hypertrophic cardiomyopathy Myosin inhibition is considered a key therapeutic approach in the treatment of obstructive hypertrophic cardiomyopathy (oHCM). In addition to mavacamten, aficamten is now being clinically investigated as a potentially short-acting,...…
View Post 6 min This content is machine translated Clinical case reports and implications for GP care Magnesium deficiency and dilated cardiomyopathy in the peripartum context Magnesium deficiency is often overlooked, but plays an important role in the pathophysiology of various internal and cardiological diseases. Particularly in the peripartum context, hypomagnesemia can have serious consequences, such...…
View Post 3 min This content is machine translated Transthyretin cardiomyopathy (TTR-CM) Pragmatic rule of thumb for rapid diagnostics An article by cardiologists Dr. Grogan and Dr. Scott Wright, published in Mayo Clinic Proceedings in 2023, describes a simple screening regimen that is particularly important for the main risk…
View Post 5 min This content is machine translated Hypertrophic obstructive cardiomyopathy Targeted drug treatment possible Hypertrophic cardiomyopathies are characterized by a thickening of the heart muscle without accompanying dilatation. In 70% of cases, there is an obstruction of the left ventricular outflow tract, which is…
View Post 2 min This content is machine translated Cardiomyopathy From risk to therapy – imaging in individual risk management When we talk about cardiomyopathy, we can be talking about different clinical pictures with different causes and symptoms. The actual cause may be genetic, acquired, or a mixture of both.…
View Post 3 min This content is machine translated Transthyretin amyloidosis with cardiomyopathy. Good survival rates with a causal treatment approach Transthyretin amyloidosis with cardiomyopathy is a significantly underdiagnosed disease that often presents with clinical symptoms of heart failure. Due to the age pyramid, the number of patients will most likely…
View Post 2 min This content is machine translated Hypertrophic cardiomyopathies (HCM) Recognize rare causes This training course is all about differential diagnosis and therapy of hypertrophic cardiomyopathies (HCM). First, the previously known etiologies and their respective frequencies are highlighted. The very large group of…
View Post 10 min This content is machine translated Cardiomyopathies Cardiac amyloidosis as a cause of heart failure. Typical of cardiac amyloidosis is the development of heart failure with preserved ejection fraction (HFpEF). New diagnostic procedures and therapeutic options are now shedding a different light on this rare,…
View Post 10 min This content is machine translated Hypertrophic cardiomyopathy (HCM) Genetics and risk stratification for sudden cardiac death. Hypertrophic cardiomyopathy (HCM) is the most common hereditary heart muscle disease. The clinical picture ranges from asymptomatic patients to manifest heart failure and sudden cardiac death (SCD). The mainstay of…
View Post 7 min This content is machine translated Cardiomyopathy Takotsubo syndrome (TTS) Takotsubo syndrome is an important differential diagnosis in patients with acute coronary syndrome and is associated with a significant risk of life-threatening complications. It predominantly affects postmenopausal women and often…
View Post 14 min This content is machine translated Basic sports medicine diagnostics for amateur athletes Imaging in athletes at cardiovascular risk. In contrast to competitive athletes, there are no generally applicable recommendations for amateur athletes regarding risk stratification for cardiovascular events. An algorithm proposed by the European Society for Cardiac Rehabilitation…
